HOOK - HOOKIPA Pharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
13,404
7,629
0
Cost of Revenue
-
-
-
Gross Profit
-
-
-
Operating Expenses
Research Development
39,748
21,965
9,772
Selling General and Administrative
13,720
6,844
4,385
Total Operating Expenses
49,079
23,197
12,088
Operating Income or Loss
-35,675
-15,568
-12,088
Interest Expense
850
778
606
Total Other Income/Expenses Net
806
133
-25
Income Before Tax
-34,579
-16,213
-12,719
Income Tax Expense
106
24
4
Income from Continuing Operations
-34,685
-16,237
-12,723
Net Income
-34,685
-16,237
-12,723
Net Income available to common shareholders
-34,685
-16,237
-12,723
Reported EPS
Basic
-
-0.99
-0.78
Diluted
-
-0.99
-0.78
Weighted average shares outstanding
Basic
-
16,324
16,324
Diluted
-
16,324
16,324
EBITDA
-
-14,795
-11,715